In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ardian Inc.

Division of Medtronic PLC
www.ardian.com

Latest From Ardian Inc.

Postmarket Surveillance Reform Board Gets Injection Of Device Industry Experience

The appointments of three device industry veterans to the Brookings-administered, and partially FDA-funded, Planning Board is intended to expand the range of input in the next phase of development of a new National Medical Device Surveillance System.

Medical Device Regulation

A Device For Hypertension After All?

Despite industry-wide contraction last year after Medtronic's SYMPLICITY, some believe a hypertension device is just around the corner. With a market estimated in the billions or even tens of billions of dollars, both Medtronic and Boston Scientific are launching redesigned studies, and a determined handful of medtech start-ups continue to pursue a device-based solution for treating hypertension with invasive and noninvasive approaches, including renal sympathetic denervation through radiofrequency, ultrasound, or drugs; neuromodulation in the forearm; and cold therapy to specialized cells in the neck.

Medical Device Innovation

A Device For Hypertension After All?

Despite industry-wide contraction last year after Medtronic's SYMPLICITY, many agree the trial was flawed, and some believe a hypertension device is just around the corner. A determined handful of medtech start-ups continue to pursue a device-based approach, most by reducing “fight-or-flight” outflow from the sympathetic nervous system.

Medical Device

SYMPLICITY Results Make Life Difficult For Renal Denervation Programs

The big slice of the device industry, from large-cap firms to venture capitalists, with some stake in the renal denervation opportunity are trying to understand the new reality now that Medtronic’s pivotal Symplicity renal denervation device trial missed its endpoint.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
  • Therapeutic Areas
  • Cardiovascular
  • Renal System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Medtronic PLC
  • United-Guardian Inc.
  • Senior Management
  • Andrew Cleeland, Pres. & CEO
    Timothy D Kahlenberg, CFO
    Denise Zarins, VP, R&D
    Gregory Bakan, VP, Sales & Mktg.
  • Contact Info
  • Ardian Inc.
    Phone: (650) 417-6555
    1380 Shorebird Way
    Mountain View, CA 94043
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register